Effects of alemtuzumab injection (chronic lymphocytic leukemia): A Synthesis of Findings from 34 Studies
- Home
- Effects of alemtuzumab injection (chronic lymphocytic leukemia)
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Effects of alemtuzumab injection (chronic lymphocytic leukemia): A Synthesis of Findings from 34 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major Research Findings
The research studies highlight the effectiveness of albuterol as a bronchodilator for various respiratory conditions. 1 demonstrated that albuterol is an effective bronchodilator, particularly when compared to isoproterenol, as it exhibits fewer side effects and a longer duration of action. 34 focused on the efficacy of levalbuterol, an enantiomer of albuterol, in treating recurrent airway obstruction in horses. It was found that levalbuterol, the active component of albuterol, offered a longer duration of effect compared to albuterol. 24 investigated the long-term effects of albuterol administration in cystic fibrosis patients. The study showed a beneficial effect from maintenance therapy with albuterol, suggesting potential long-term improvements in lung function. 26 explored the dose-response of levalbuterol versus racemic albuterol in asthma patients. This study indicated that levalbuterol provided significant bronchodilatory activity and was well-tolerated, suggesting a potential benefit in managing asthma.
Benefits and Risks
Benefit Summary
Albuterol has demonstrated significant benefits in the treatment of various respiratory conditions such as asthma, chronic obstructive pulmonary disease, and bronchiolitis. It effectively relaxes the airway muscles, making breathing easier for patients. 1 , 34 , 24 , 26 Moreover, albuterol has been shown to have a longer duration of action compared to some other bronchodilators, potentially leading to improved symptom control and a better quality of life for patients. 1 , 34
Risk Summary
While albuterol is generally safe and well-tolerated, some potential side effects can occur. These may include tremors, palpitations, and nervousness. 1 In some cases, high doses of albuterol may cause a decrease in potassium levels, which can potentially lead to heart rhythm problems. 8 It is crucial to use albuterol as prescribed by a doctor and to monitor for any adverse effects. 1
Comparison Across Studies
Commonalities
All these studies consistently demonstrate the effectiveness of albuterol and its enantiomer, levalbuterol, in improving respiratory function in patients with various respiratory conditions. 1 , 34 , 24 , 26
Differences
These studies differ in their focus, patient populations, and specific parameters measured. 1 , 34 , 24 , 26 For instance, 1 focused on comparing albuterol to isoproterenol, while 34 examined the efficacy of levalbuterol in horses. The study in cystic fibrosis patients 24 investigated the long-term effects of albuterol, while the study in asthma patients 26 compared the dose-response of levalbuterol and racemic albuterol.
Consistency and Discrepancies
While the overall findings demonstrate the benefits of albuterol in improving respiratory function, there are some discrepancies in the results. 1 For example, some studies found that albuterol had a longer duration of action than isoproterenol, while others focused on the dose-response of albuterol and levalbuterol in specific populations. 26 Further research is needed to fully understand the nuances of albuterol’s effects in various respiratory conditions.
Considerations for Real-World Application
While albuterol is a valuable tool in managing respiratory conditions, it’s crucial to use it as prescribed by a doctor. 1 It’s important to be aware of potential side effects and to report any unusual symptoms. 1 Additionally, doctors should consider the potential interactions between albuterol and other medications a patient may be taking. 8 It’s important to consult with a healthcare professional for personalized advice on the use of albuterol.
Limitations of Current Research
Some studies have limitations, such as a small sample size or a focus on specific patient populations, which may limit the generalizability of their findings. 1 , 24 Further research is needed to address these limitations and provide a comprehensive understanding of albuterol’s effects.
Future Research Directions
Future research should investigate the long-term effects of albuterol therapy, particularly in specific patient groups. 24 Additional research is needed to assess the optimal dosing and administration strategies for albuterol, considering individual patient factors and specific respiratory conditions. 31 Further studies are needed to explore the mechanisms by which albuterol exerts its bronchodilatory effects and its potential interactions with other medications. 8
Conclusion
Albuterol, including its enantiomer levalbuterol, has proven to be an effective bronchodilator, offering significant relief for patients with respiratory conditions. 1 , 34 , 24 , 26 While generally safe, it is essential to use albuterol as prescribed by a doctor and to monitor for any potential side effects. 1 Future research will further elucidate the long-term effects and optimal usage of albuterol in various respiratory conditions. 24 , 31
Benefit Keywords
Risk Keywords
Article Type
Author: SpectorS L, Garza GomezM
Language : English
Author: VilsvikJ, SchaanningJ, StåhlE, HoltheS
Language : English
Author: TwentymanO P, FinnertyJ P, HolgateS T
Language : English
Comparison of albuterol to isoproterenol as a bronchodilator for use in pulmonary function testing.
Author: CasaburiR, AdameD, HongC K
Language : English
Author: SchuhS, CannyG, ReismanJ J, KeremE, BenturL, PetricM, LevisonH
Language : English
Author: VathenenA S, BrittonJ R, EbdenP, CooksonJ B, WharradH J, TattersfieldA E
Language : English
Author: KempJ P, FurukawaC T, BronskyE A, GrossmanJ, LemanskeR F, MansfieldL E, MurphyS, RatnerP H, ReeseM E, RogenesP R
Language : English
Author: LipworthB J, McDevittD G, StruthersA D
Language : English
Author: MunzenbergerP J, PapaioanouH A, MassoudN
Language : English
Author: SchuhS, ParkinP, RajanA, CannyG, HealyR, RiederM, TanY K, LevisonH, SoldinS J
Language : English
Author: BronskyE, BucholtzG A, BusseW W, ChervinskyP, CondemiJ, GhafouriM A, HudsonL, LakshminarayanS, LockeyR, ReeseM E
Language : English
Author: JoadJ P, AhrensR C, LindgrenS D, WeinbergerM M
Language : English
Author: PiersonW E, ShapiroG G, FurukawaC T, BiermanC W
Language : English
Author: KönigP, HordvikN L, SunderrajanE V
Language : English
Author: LittnerM R, TashkinD P, SiegelS C, KatzR
Language : English
Author: RachelefskyG S, KatzR M, SiegelS C
Language : English
Author: LinR Y, SauterD, NewmanT, SirleafJ, WaltersJ, TavakolM
Language : English
Effects of combined treatment with glycopyrrolate and albuterol in acute exacerbation of asthma.
Author: CydulkaR K, EmermanC L
Language : English
Author: ShresthaM, GourlayS, RobertsonS, BidadiK, WainscottM, HayesJ
Language : English
Author: BremnerP, SiebersR, CraneJ, BeasleyR, BurgessC
Language : English
Author: ShresthaM, BidadiK, GourlayS, HayesJ
Language : English
Author: DrazenJ M, IsraelE, BousheyH A, ChinchilliV M, FahyJ V, FishJ E, LazarusS C, LemanskeR F, MartinR J, PetersS P, SorknessC, SzeflerS J
Language : English
Author: YatesD H, WorsdellM, BarnesP J
Language : English
Author: KönigP, PoehlerJ, BarberoG J
Language : English
Author: NelsonH S, BerkowitzR B, TinkelmanD A, EmmettA H, RickardK A, YanceyS W
Language : English
Author: HandleyD A, TinkelmanD, NoonanM, RollinsT E, SniderM E, CaronJ
Language : English
Language : English
Author: CrowellM D, ZayatE N, LacyB E, Schettler-DuncanA, LiuM C
Language : English
The therapeutic ratio of R-albuterol is comparable with that of RS-albuterol in asthmatic patients.
Author: LötvallJ, PalmqvistM, ArvidssonP, MaloneyA, VentrescaG P, WardJ
Language : English
Author: AbramsonMichael J, WaltersJulia, WaltersE Haydn
Language : English
Author: NairSuresh, ThomasEnson, PearsonStanley B, HenryMichael T
Language : English
Author: LeeDavid Lin, HsuChien-Wei, LeeHuan, ChangHsueh-Wen, HuangYuh-Chin T
Language : English
Author: JatKana Ram, KhairwaAnju
Language : English
Efficacy of Inhaled Levalbuterol Compared to Albuterol in Horses with Recurrent Airway Obstruction.
Author: ArroyoM G, CouëtilL L, NogradiN, KamarudinM M, IvesterK M
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.